Caption Management, LLC Seagen Inc. Put Options Transaction History

Caption Management, LLC

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $109 Million - $123 Million	570,800 Added 2060.65%	598,500 $127 Million
Q2 2023 Aug 14, 2023	SELL	$187.64 - $206.25 $22.9 Million - $25.2 Million	-122,300 Reduced 81.53%	27,700 $5.33 Million
Q1 2023 May 15, 2023	BUY	$127.59 - $203.08 $19.1 Million - $30.5 Million	150,000 New	150,000 $30.4 Million
Q3 2022 Nov 14, 2022	BUY	$135.27 - $180.11 $6.71 Million - $8.93 Million	49,600 Added 330.67%	64,600 $8.84 Million
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $1.96 Million - $3.23 Million	-18,000 Reduced 54.55%	15,000 $2.65 Million
Q1 2022 May 13, 2022	SELL	$119.61 - $157.85 $5.98 Million - $7.89 Million	-50,000 Reduced 60.24%	33,000 $4.76 Million
Q4 2021 Feb 11, 2022	BUY	$142.57 - $190.86 $3.28 Million - $4.39 Million	23,000 Added 38.33%	83,000 $12.8 Million
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $2.16 Million - $2.58 Million	16,000 Added 36.36%	60,000 $9.47 Million
Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $6.05 Million - $8.4 Million	44,000 New	44,000 $6.11 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.